LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Criminal Law and Procedure
Estate and Elder Law
Financial Fraud Law
Fracking and Alternative Energy
Labor and Employment Law
Media and Entertainment
Mergers and Acquisitions
Real Estate Law
Top Emerging Trends
NEWS & INSIGHT
Blogs and Newsletters
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
News & Trending Topics
Legal Insights & Trends
Lexis Practice Advisor Journal
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Browse By Tags
Actavis Elizabeth LLC
failure to warn
Food and Drug Administration
Inc. v. Mensing
Schwarz Pharma Inc.
Teva Pharmaceuticals USA
Teva Pharmaceuticals USA Inc.
U.S. Supreme Court
Wyeth v. Levine
over 8 years ago
U.S. Supreme Court To Decide Whether Claims About Generic Drugs Are Preempted
WASHINGTON, D.C. -- (Mealey's) The U.S. Supreme Court on Dec. 10 agreed to decide whether the Hatch Waxman Act prevents manufacturers of generic drugs from adding new warnings to drug labels as new risks become known ( Pliva, Inc. v. Gladys Mensing...
over 6 years ago
Alabama High Court Says Wyeth Can Be Liable For Injuries Caused By Generic Drug
MONTGOMERY, Ala. - (Mealey's) An 8-1 majority of the Alabama Supreme Court on Jan. 11 ruled that Wyeth can be held liable for failing to warn doctors about the risk of long-term use of Reglan if a patient was injured by metoclopramide, the generic...
over 5 years ago
Alabama High Court Again Says Brand-Name Drug Makers Liable In Generic Injury Case
MONTGOMERY, Ala. —(Mealey’s) A brand-name drug manufacturer may be liable under Alabama law for fraud or misrepresentation in a drug label used by generic drug makers, the Alabama Supreme Court held Aug. 15 after reconsidering its 2013 decision...
over 4 years ago
Failure-To-Update Claims For Generic Drugs Not Preempted In New Jersey, Court Says
TRENTON, N.J. — (Mealey’s) A New Jersey state appeals court panel on Nov. 12 affirmed a lower court ruling that generic drug manufacturers can be sued for failure to update their labels with warnings added to the labels of the predecessor...
over 6 years ago
5th Circuit: Mensing Doesn't Make Brand-Name Defendants Liable For Injuries
NEW ORLEANS - (Mealey's) The U.S. Supreme Court's ruling that preempts failure-to-warn claims involving generic drugs does not change Louisiana state law and make manufacturers of brand-name versions liable, a Fifth Circuit U.S. Court of Appeals...
over 6 years ago
Failure To Update Generic Metoclopramide Label Not Preempted, 6th Circuit Says
CINCINNATI - (Mealey's) A plaintiff's claim that PLIVA Inc. failed to add a 2004 warning from the Reglan label to its label for generic metoclopramide is not preempted, a panel of the Sixth Circuit U.S. Court of Appeals said March 13 in what it...
Latin America and the Caribbean
Europe, Africa and Middle East
International Sales(Includes Middle East)
Rule of Law
Top Product Pages
Sign-In Index Page
Legal & Professional Solutions
Terms & Conditions